Researchers find their Nemo.
With its genome almost fully sequenced, the zebrafish has gone from bit player to rising star among model organisms. Its lower maintenance costs and the ease of tissue imaging in live zebrafish are among the benefits that have cast this organism as an emerging player in disease research and drug screening.